Cory Scrivner

Cory Scrivner is a seasoned professional in the ophthalmic pharmaceutical industry, currently serving as a Key Account Manager at Harrow since May 2025. In this role, Cory is responsible for the sales and promotion of TRIESENCE, an injectable buy and bill steroid, and IHEEZO, a buy and bill topical anesthetic in the Retina market. Prior to this position, Cory held the role of Senior Territory Manager at Bausch + Lomb, where the promotion of dry eye products Miebo and Xiidra was emphasized. Experience also includes serving as a Retina Account Manager at Alimera Sciences, where responsibilities included sales and physician training for YUTIQ and ILUVIEN, along with time as a Key Account Manager at EyePoint Pharmaceuticals, focusing on training Retina residents and specialists. Earlier career highlights include launching Inveltys and Eysuvis at Kala Pharmaceuticals as a Territory Sales Manager. Cory holds a Bachelor of Science degree in Microbiology from California Polytechnic State University-San Luis Obispo.